Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.05m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Net Asset Value & Final Dividend

21 Apr 2020 17:17

RNS Number : 4086K
Maven Income & Growth VCT PLC
21 April 2020
 

Maven Income and Growth VCT PLC

 

Net Asset Value

 

The Directors of Maven Income and Growth VCT PLC (the Company) confirm that the unaudited net asset value (NAV) of the Company as at 29 February 2020 was 46.35p per Ordinary Share.

 

Subsequent to the year end, having assessed the likely impact across the portfolio from the global COVID-19 pandemic, the Directors announced on 26 March 2020 that, as at 20 March 2020, the unaudited NAV of the Company was 43.49p per share.

 

The NAVs as at 29 February and 20 March 2020 are both unaudited and reflect the closing bid prices of quoted securities as at that date. Investments in unlisted companies are normally valued on a six-monthly basis and the NAV as at 20 March 2020 incorporates the Directors' valuation of unlisted investments as at 29 February 2020, adjusted for subsequent events where appropriate. The Board and the Manager remain in regular contact as they review the evolving COVID-19 situation, and its impact on the Company's portfolio and NAV. Further updates will be provided to Shareholders when required.

 

Final Dividend

 

Whilst your Company does not have a specific dividend target, the Board and the Manager recognise the importance of tax-free distributions to Shareholders and, following recent realisation activity, are pleased to propose a final dividend of 2.00p per Ordinary Share in respect of the year ended 29 February 2020. Subject to Shareholder approval at the 2020 AGM, the final dividend will be paid on 31 July 2020 to Shareholders on the register at 3 July 2020 and will bring total distributions for the year to 4.00p per Ordinary Share.

 

Dividend Investment Scheme (DIS)

 

As announced on 26 March 2020, in light of the current volatility in financial markets caused by the COVID-19 pandemic, the Board had decided that it was appropriate to suspend the DIS. Therefore, until further notice, all subsequent dividends, including the above final distribution proposed in respect of the year ended 29 February 2020, will be paid to all Shareholders by either cheque or by bank transfer using existing mandate instructions. Written confirmation of this suspension in the operation of the DIS will be issued to those Shareholders who have elected to participate.

 

Further to the information disclosed above, the Directors confirm that they are satisfied that all inside information (as defined by Article 7 of the Market Abuse Regulation (596/2014/EU)) that the Directors and the Company may have in their possession relating to the Company during the 30 day close period leading up to the announcement of its annual results for the year ended 29 February 2020 has been notified to a regulatory information service.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Secretary

21 April 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NAVKKDBDABKDNQB
Date   Source Headline
2nd Jun 20264:19 pmRNSAnnual Financial Report
1st May 20263:20 pmRNSTransaction in Own Shares
30th Apr 20265:09 pmRNSTransaction in Own Shares
30th Apr 202610:51 amRNSAdmission of Further Securities to Trading
29th Apr 202612:23 pmRNSIssue of Equity
27th Apr 20263:29 pmRNSUnaudited Net Asset Value and Dividend Declaration
20th Apr 202612:23 pmRNSPublication of a Supplementary Prospectus
15th Apr 202611:17 amRNSAdmission of Further Securities to Trading
14th Apr 202611:06 amRNSIssue of Equity
8th Apr 20269:27 amRNSAdmission of Further Securities to Trading
25th Mar 202610:49 amRNSAdmission of Further Securities to Trading
24th Mar 202612:08 pmRNSIssue of Equity
4th Feb 20267:00 amRNSStatement re Offer for Subscription
29th Jan 20264:54 pmRNSTransaction in Own Shares
21st Jan 202611:01 amRNSAdmission of Further Securities to Trading
20th Jan 20262:05 pmRNSAdmission of Further Securities to Trading
16th Jan 20269:39 amRNSIssue of Equity
15th Jan 202610:27 amRNSDirector/PDMR Shareholding
15th Jan 202610:26 amRNSDirector/PDMR Shareholding
15th Jan 202610:26 amRNSDirector/PDMR Shareholding
15th Jan 20269:50 amRNSIssue of Equity
14th Jan 20262:33 pmRNSUnaudited NAV - Dividend Investment Scheme
4th Dec 202510:35 amRNSUnaudited NAV and Second Interim Dividend
13th Nov 20253:39 pmRNSResult of General Meeting
29th Oct 20257:00 amRNSHalf-year Report
16th Oct 20254:43 pmRNSTransaction in Own Shares
2nd Oct 20254:42 pmRNSPublication of a Prospectus
15th Sep 20251:06 pmRNSNet Asset Value(s)
29th Aug 20257:00 amRNSIssue of Equity
20th Aug 20252:12 pmRNSStatement re Dividend Investment Scheme
23rd Jul 20254:33 pmRNSTransaction in Own Shares
18th Jul 202510:08 amRNSIssue of Equity - Dividend Investment Scheme
16th Jul 20257:08 amRNSStatement re Offer for Subscription
11th Jul 20253:56 pmRNSStatement re Dividend Investment Scheme
11th Jul 20252:58 pmRNSStatement re Unaudited NAV and Interim Dividend
10th Jul 20252:32 pmRNSResult of AGM
28th May 20254:18 pmRNSAnnual Financial Report
7th May 20254:35 pmRNSTransaction in Own Shares
6th May 202511:51 amRNSIssue of Equity
25th Apr 20254:19 pmRNSUnaudited NAV and Proposed Final Dividend
17th Apr 202512:56 pmRNSPublication of Suppl.Prospcts
7th Apr 20257:00 amRNSIssue of Equity - Replacement
4th Apr 20256:15 pmRNSIssue of Equity
1st Apr 202512:59 pmRNSStatement re Offers for Subscription - Closed
27th Mar 20251:02 pmRNSIssue of Equity
27th Mar 202510:25 amRNSUpdate re: Offers for Subscription
24th Mar 20253:23 pmRNSUnaudited Net Asset Value
29th Jan 20254:35 pmRNSTransaction in Own Shares
28th Jan 202512:15 pmRNSStatement re Offer for Subscription
28th Jan 202511:27 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.